在线发表了上海交通大学医学院附属仁济医院风湿科叶霜教授团队领衔的多中心真实世界研究《Effectiveness and safety of tofacitinib versus calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a ...

Dermatomyositis (DM ... in particular with interstitial lung disease or cardiovascular involvement, and increased rates of malignancy. Dr. Julie Paik is an Associate Professor of Medicine in ...

Dermatomyositis (DM ... and the absence of interstitial lung disease are other predictive factors of malignancy. There is decreasing malignancy risk over time, and the first 3 years following ...

Immunoglobulin A and the Risk of Rapidly Progressive Interstitial Lung Disease in Dermatomyositis These researchers found that serum IgA may be a novel independent risk factor for rapidly ...

Interstitial lung disease (ILD) is a broad term for a group of conditions that cause lung inflammation and/or fibrosis (scarring). Lung damage from ILD can make breathing difficult, leading to ...